| |
|
|
|
AcelRx Pharmaceuticals Inc.  
|
|
1.06 -0.08 (-0.07%) |
07-06 16:00 |
|
Open: |
1.15 |
Pre close: |
1.14 |
Target:
|
1.60 
|
|
High: |
1.2 |
Low: |
1.03 |
Resistance:
|
1.37
1.58
|
|
Volume: |
1,589,698 |
Market Cap: |
86M |
Support:
|
1.03
0.86
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.16
|
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
1.31 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
1.34 |
Stochastic Oscillator |
%K(14,3):
|
5.26 |
|
MA(250): |
1.83 |
%D(3): |
7.87 |
|
Average Volume(K) |
3-Month: |
111339
|
52-Week |
High:
|
3.02 |
|
10-Days: |
94499 |
Low: |
0.70 |
|
RSI |
RSI(14):
|
31.33 |
Change(%): |
-60.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.698 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
80.76 |
|
EPS Est. Current Year |
-1.120 |
Return on Assets (ttm) |
-36.7 |
Shares Float (M) |
79.42 |
|
EPS Est. Next Year |
-0.940 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.87 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
45.7 |
% Held by Institutions |
24.01 |
|
Forward EPS |
-0.810 |
Gross Profit (p.s.) |
-0.114 |
Shares Short (K) |
9210 |
|
Book Value (p.s.) |
-0.690 |
EBITDA (p.s.) |
-0.670 |
P/E |
-1.52 |
|
Sales Per Share |
0.030 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.54 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-52.30 |
P/S |
35.52 |
|
Operating Margin |
-2320.95 |
Levered Free Cash Flow
(M) |
-32.01 |
P/CF |
-1.64 |
|
|
|
|
|
|
